XOMA Corp XOMA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
24.05UNCH (UNCH)
Volume
928
Close
24.05UNCH (UNCH)
Volume
18,906
52 week range
13.48 - 26.83
Loading...
  • Open23.25
  • Day High24.54
  • Day Low23.25
  • Prev Close23.34
  • 52 Week High26.83
  • 52 Week High Date03/18/24
  • 52 Week Low13.48
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap279.601M
  • Shares Out11.63M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change30

KEY STATS

  • Open23.25
  • Day High24.54
  • Day Low23.25
  • Prev Close23.34
  • 52 Week High26.83
  • 52 Week High Date03/18/24
  • 52 Week Low13.48
  • 52 Week Low Date10/04/23
  • Market Cap279.601M
  • Shares Out11.63M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change30

RATIOS/PROFITABILITY

  • EPS (TTM)-4.04
  • P/E (TTM)-5.95
  • Fwd P/E (NTM)-9.72
  • EBITDA (TTM)-25.12M
  • ROE (TTM)-27.24%
  • Revenue (TTM)4.758M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-858.15%
  • Debt To Equity (MRQ)139.83%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On XOMA Corp

 

Profile

MORE
XOMA Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. Its royalty portfolio includes DAY101...
Jack Wyszomierski
Independent Chairman of the Board
Owen Hughes Jr.
Chief Executive Officer, Director
Thomas Burns
Chief Financial Officer, Senior Vice President - Finance
Address
Suite 310, 2200 Powell Street
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
IPSC
Century Therapeutics Inc
4.18UNCHUNCH
STOK
Stoke Therapeutics Inc
13.50UNCHUNCH
RAPT
RAPT Therapeutics Inc
8.98UNCHUNCH
CMPX
Compass Therapeutics Inc.
1.98UNCHUNCH
BDTX
Black Diamond Therapeutics Inc
5.07UNCHUNCH